
Allogene Therapeutics, Inc.
ALLOHealthcare|Biotechnology|US
$1.04
-0.05 (-4.59%)
Tangible Book / Share
$1.13
Cash / Share
$0.85
Ownership Breakdown
74.6%
Float
345.5M
Shares Outstanding
257.8M
Float Shares
Major Holders (36)
Combined: 78.2%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Pfizer Inc. | Corporation | 9.00% | 22,032,040 | Feb 13, 2026 | 13D/G |
| BlackRock, Inc. | Holding company | 6.70% | 23,211,736 | Oct 27, 2026 | 13D/G |
| Frazier Life Sciences Public Fund, L.P. | Partnership | 5.60% | 19,445,046 | Aug 14, 2026 | 13D/G |
| FHMLSP, L.P. | Partnership | 5.60% | 19,445,046 | Aug 14, 2026 | 13D/G |
| FHMLSP, L.L.C. | Other | 5.60% | 19,445,046 | Aug 14, 2026 | 13D/G |
| State Street Corporation | Holding company | 5.50% | 19,025,826 | Aug 7, 2026 | 13D/G |
| David D. Chang, M.D., Ph.D. | Individual | 4.90% | 12,297,354 | May 13, 2026 | 13D/G |
| FMR LLC | Holding company | 4.90% | 10,225,851 | Mar 7, 2025 | 13D/G |
| Abigail P. Johnson | Individual | 4.90% | 10,225,851 | Mar 7, 2025 | 13D/G |
| The Vanguard Group | Investment adviser | 3.98% | 8,327,699 | Nov 12, 2024 | 13D/G |
| Arie Belldegrun, M.D. | Individual | 3.90% | 13,610,578 | Aug 7, 2026 | 13D/G |
| Kenneth Griffin | HC, IN | 2.80% | 6,855,120 | May 15, 2026 | 13D/G |
| Citadel Advisors LLC | IA, HC, OO | 2.40% | 5,795,242 | May 15, 2026 | 13D/G |
| Citadel Advisors Holdings LP | HC, PN | 2.40% | 5,795,242 | May 15, 2026 | 13D/G |
| Citadel GP LLC | HC, OO | 2.40% | 5,795,242 | May 15, 2026 | 13D/G |
| Bellco Legacy IV LLC | Other | 1.30% | 4,710,120 | Aug 7, 2026 | 13D/G |
| FHMLS Xii, L.P. | Partnership | 0.60% | 1,941,465 | Aug 14, 2026 | 13D/G |
| Frazier Life Sciences XII, L.P. | Partnership | 0.60% | 1,941,465 | Aug 14, 2026 | 13D/G |
| FHMLS Xii, L.L.C. | Other | 0.60% | 1,941,465 | Aug 14, 2026 | 13D/G |
| Vida Ventures III, L.P. | Other | 0.50% | 1,720,172 | Aug 7, 2026 | 13D/G |
| Vida Ventures LLC | Other | 0.50% | 1,798,163 | Aug 7, 2026 | 13D/G |
| Chang 2006 Family Trust | Other | 0.50% | 1,201,108 | May 13, 2026 | 13D/G |
| Citadel Securities GP LLC | HC, OO | 0.40% | 1,059,878 | May 15, 2026 | 13D/G |
| Citadel Securities Group LP | HC, PN | 0.40% | 1,059,878 | May 15, 2026 | 13D/G |
| Citadel Securities LLC | BD, OO | 0.30% | 614,069 | May 15, 2026 | 13D/G |
| JEC 2019 Trust | Other | 0.30% | 856,044 | May 13, 2026 | 13D/G |
| RTC 2019 Trust | Other | 0.30% | 856,044 | May 13, 2026 | 13D/G |
| FHMLS XI, L.L.C. | Other | 0.20% | 753,251 | Aug 14, 2026 | 13D/G |
| Frazier Life Sciences XI, L.P. | Partnership | 0.20% | 753,251 | Aug 14, 2026 | 13D/G |
| FHMLS XI, L.P. | Partnership | 0.20% | 753,251 | Aug 14, 2026 | 13D/G |
| Bellco Legacy LLC | Other | 0.20% | 539,867 | Aug 7, 2026 | 13D/G |
| Patrick J. Heron | Individual | 0.10% | 306,906 | Aug 14, 2026 | 13D/G |
| James N. Topper | Individual | 0.10% | 306,906 | Aug 14, 2026 | 13D/G |
| FHMLS X, L.P. | Partnership | 0.10% | 306,906 | Aug 14, 2026 | 13D/G |
| Frazier Life Sciences X, L.P. | Partnership | 0.10% | 306,906 | Aug 14, 2026 | 13D/G |
| FHMLS X, L.L.C. | Other | 0.10% | 306,906 | Aug 14, 2026 | 13D/G |
Insider Trades (100)
Last 4 quarters: 7,363,852 acquired · 401,777 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Parker Geoffrey M. | CHIEF FINANCIAL OFFICER | Oct 21, 2026 | SELL | 36,342 | $1.34 | $48.7K | Form 4 |
| Douglas Earl Martin | SVP, General Counsel | Aug 21, 2026 | SELL | 29,697 | $2.12 | $63.0K | Form 4 |
| Roberts Zachary | President and CEO | Jul 1, 2026 | AWARD | 476,190 | $2.11 | $1.0M | Form 4 |
| Roberts Zachary | President and CEO | Jul 1, 2026 | AWARD | 134,530 | — | — | Form 4 |
| Kazam Joshua A | director | Jun 18, 2026 | OPTION EX. | 47,700 | — | — | Form 4 |
| Kazam Joshua A | director | Jun 18, 2026 | AWARD | 95,400 | — | — | Form 4 |
| Kazam Joshua A | director | Jun 18, 2026 | OPTION EX. | 47,700 | — | — | Form 4 |
| MESSEMER DEBORAH M. | director | Jun 18, 2026 | AWARD | 95,400 | — | — | Form 4 |
| Mayo Stephen | director | Jun 18, 2026 | AWARD | 144,400 | $2.00 | $288.8K | Form 4 |
| SATO VICKI L | director | Jun 18, 2026 | AWARD | 95,400 | — | — | Form 4 |
| WITTE OWEN N. | director | Jun 18, 2026 | AWARD | 95,400 | — | — | Form 4 |
| Humer Franz B | director | Jun 18, 2026 | AWARD | 95,400 | — | — | Form 4 |
| Barrett Elizabeth A. | director | Jun 18, 2026 | AWARD | 95,400 | — | — | Form 4 |
| Yoshiyama Annie | SVP, Finance | Apr 21, 2026 | SELL | 9,586 | $2.31 | $22.1K | Form 4 |
| Beneski Benjamin Machinas | SVP, Chief Technical Officer | Mar 31, 2026 | SELL | 2,867 | $2.50 | $7.2K | Form 4 |
| Beneski Benjamin Machinas | SVP, Chief Technical Officer | Mar 16, 2026 | SELL | 4,835 | $2.47 | $11.9K | Form 4 |
| Chang David D | director, officer: President and CEO | Mar 16, 2026 | SELL | 47,763 | $2.47 | $118.0K | Form 4 |
| Beneski Benjamin Machinas | SVP, Chief Technical Officer | Mar 2, 2026 | SELL | 7,132 | $2.60 | $18.5K | Form 4 |
| Beneski Benjamin Machinas | SVP, Chief Technical Officer | Feb 2, 2026 | AWARD | 373,757 | $1.87 | $698.9K | Form 4 |
| Beneski Benjamin Machinas | SVP, Chief Technical Officer | Feb 2, 2026 | SELL | 7,549 | $1.73 | $13.1K | Form 4 |
| Beneski Benjamin Machinas | SVP, Chief Technical Officer | Feb 2, 2026 | AWARD | 105,720 | — | — | Form 4 |
| Chang David D | director, officer: President and CEO | Feb 2, 2026 | SELL | 95,269 | $1.80 | $171.5K | Form 4 |
| Chang David D | director, officer: President and CEO | Feb 2, 2026 | AWARD | 1,387,931 | $1.87 | $2.6M | Form 4 |
| Chang David D | director, officer: President and CEO | Feb 2, 2026 | AWARD | 392,586 | — | — | Form 4 |
| Parker Geoffrey M. | CHIEF FINANCIAL OFFICER | Feb 2, 2026 | SELL | 24,001 | $1.76 | $42.2K | Form 4 |
| Parker Geoffrey M. | CHIEF FINANCIAL OFFICER | Feb 2, 2026 | AWARD | 539,072 | $1.87 | $1.0M | Form 4 |
| Parker Geoffrey M. | CHIEF FINANCIAL OFFICER | Feb 2, 2026 | AWARD | 152,480 | — | — | Form 4 |
| Douglas Earl Martin | SVP, General Counsel | Feb 2, 2026 | SELL | 22,900 | $1.76 | $40.3K | Form 4 |
| Douglas Earl Martin | SVP, General Counsel | Feb 2, 2026 | AWARD | 539,072 | $1.87 | $1.0M | Form 4 |
| Douglas Earl Martin | SVP, General Counsel | Feb 2, 2026 | AWARD | 152,480 | — | — | Form 4 |
| Yoshiyama Annie | SVP, Finance | Feb 2, 2026 | AWARD | 179,691 | $1.87 | $336.0K | Form 4 |
| Yoshiyama Annie | SVP, Finance | Feb 2, 2026 | SELL | 4,167 | $1.72 | $7.2K | Form 4 |
| Yoshiyama Annie | SVP, Finance | Feb 2, 2026 | AWARD | 50,827 | — | — | Form 4 |
| Roberts Zachary | EVP of R&D | Feb 2, 2026 | AWARD | 718,763 | $1.87 | $1.3M | Form 4 |
| Roberts Zachary | EVP of R&D | Feb 2, 2026 | SELL | 35,700 | $1.77 | $63.2K | Form 4 |
| Roberts Zachary | EVP of R&D | Feb 2, 2026 | AWARD | 203,307 | — | — | Form 4 |
| Belldegrun Arie | director | Feb 2, 2026 | AWARD | 929,913 | $1.87 | $1.7M | Form 4 |
| Belldegrun Arie | director | Feb 2, 2026 | AWARD | 263,033 | — | — | Form 4 |
| Roberts Zachary | EVP of R&D | Jan 21, 2026 | SELL | 26,269 | $1.56 | $41.0K | Form 4 |
| Kazam Joshua A | director | Dec 18, 2025 | OPTION EX. | 47,700 | — | — | Form 4 |
| Kazam Joshua A | director | Dec 18, 2025 | OPTION EX. | 47,700 | — | — | Form 4 |
| Beneski Benjamin Machinas | SVP, Chief Technical Officer | Nov 17, 2025 | SELL | 786 | $1.22 | $958.92 | Form 4 |
| Parker Geoffrey M. | CHIEF FINANCIAL OFFICER | Oct 21, 2025 | SELL | 36,744 | $1.26 | $46.2K | Form 4 |
| SATO VICKI L | director | Jun 18, 2025 | AWARD | 144,400 | $1.29 | $186.3K | Form 4 |
| MESSEMER DEBORAH M. | director | Jun 18, 2025 | AWARD | 95,400 | — | — | Form 4 |
| Humer Franz B | director | Jun 18, 2025 | AWARD | 95,400 | — | — | Form 4 |
| Barrett Elizabeth A. | director | Jun 18, 2025 | AWARD | 95,400 | — | — | Form 4 |
| Mayo Stephen | director | Jun 18, 2025 | AWARD | 95,400 | — | — | Form 4 |
| WITTE OWEN N. | director | Jun 18, 2025 | AWARD | 95,400 | — | — | Form 4 |
| Kazam Joshua A | director | Jun 18, 2025 | AWARD | 94,500 | — | — | Form 4 |
| MESSEMER DEBORAH M. | director | Jun 10, 2025 | SELL | 36,885 | $1.42 | $52.4K | Form 4 |
| Yoshiyama Annie | SVP, Finance | Apr 21, 2025 | SELL | 9,601 | $1.41 | $13.5K | Form 4 |
| Chang David D | director, officer: President and CEO | Mar 14, 2025 | SELL | 46,668 | $1.96 | $91.5K | Form 4 |
| Beneski Benjamin Machinas | SVP, Chief Technical Officer | Mar 14, 2025 | SELL | 5,488 | $1.98 | $10.8K | Form 4 |
| Beneski Benjamin Machinas | SVP, Chief Technical Officer | Mar 1, 2025 | AWARD | 31,755 | — | — | Form 4 |
| Beneski Benjamin Machinas | SVP, Chief Technical Officer | Mar 1, 2025 | AWARD | 112,339 | $1.80 | $202.2K | Form 4 |
| Beneski Benjamin Machinas | SVP, Chief Technical Officer | Mar 1, 2025 | OTHER | 0 | — | — | Form 4 |
| Beneski Benjamin Machinas | SVP, Chief Technical Officer | Mar 1, 2025 | OTHER | 9,014 | $9.69 | $87.3K | Form 4 |
| Beneski Benjamin Machinas | SVP, Chief Technical Officer | Mar 1, 2025 | OTHER | 43,698 | $1.94 | $84.8K | Form 4 |
| Beneski Benjamin Machinas | SVP, Chief Technical Officer | Mar 1, 2025 | OTHER | 24,428 | $5.04 | $123.1K | Form 4 |
| Beneski Benjamin Machinas | SVP, Chief Technical Officer | Mar 1, 2025 | OTHER | 54,314 | $13.31 | $722.9K | Form 4 |
| MESSEMER DEBORAH M. | director | Feb 18, 2025 | SELL | 13,313 | $2.43 | $32.4K | Form 4 |
| Douglas Earl Martin | SVP, General Counsel | Feb 3, 2025 | SELL | 6,404 | $1.71 | $11.0K | Form 4 |
| Parker Geoffrey M. | CHIEF FINANCIAL OFFICER | Feb 3, 2025 | SELL | 4,361 | $1.73 | $7.5K | Form 4 |
| MOORE TIMOTHY L. | Chief Technical Officer | Feb 3, 2025 | SELL | 14,746 | $1.71 | $25.2K | Form 4 |
| Chang David D | director, officer: President and CEO | Feb 3, 2025 | SELL | 46,003 | $1.68 | $77.3K | Form 4 |
| Roberts Zachary | EVP of R&D | Feb 3, 2025 | SELL | 18,832 | $1.70 | $32.0K | Form 4 |
| Douglas Earl Martin | SVP, General Counsel | Jan 24, 2025 | AWARD | 144,928 | — | — | Form 4 |
| Douglas Earl Martin | SVP, General Counsel | Jan 24, 2025 | AWARD | 512,370 | $1.94 | $994.0K | Form 4 |
| Parker Geoffrey M. | CHIEF FINANCIAL OFFICER | Jan 24, 2025 | AWARD | 173,913 | — | — | Form 4 |
| Parker Geoffrey M. | CHIEF FINANCIAL OFFICER | Jan 24, 2025 | AWARD | 614,844 | $1.94 | $1.2M | Form 4 |
| Yoshiyama Annie | SVP, Finance | Jan 24, 2025 | AWARD | 36,232 | — | — | Form 4 |
| Yoshiyama Annie | SVP, Finance | Jan 24, 2025 | AWARD | 128,093 | $1.94 | $248.5K | Form 4 |
| Roberts Zachary | EVP of R&D | Jan 24, 2025 | AWARD | 173,913 | — | — | Form 4 |
| Roberts Zachary | EVP of R&D | Jan 24, 2025 | AWARD | 614,844 | $1.94 | $1.2M | Form 4 |
| Belldegrun Arie | director | Jan 24, 2025 | AWARD | 369,957 | — | — | Form 4 |
| Belldegrun Arie | director | Jan 24, 2025 | AWARD | 1,307,927 | $1.94 | $2.5M | Form 4 |
| Chang David D | director, officer: President and CEO | Jan 24, 2025 | AWARD | 552,174 | — | — | Form 4 |
| Chang David D | director, officer: President and CEO | Jan 24, 2025 | AWARD | 1,952,130 | $1.94 | $3.8M | Form 4 |
| Roberts Zachary | EVP of R&D | Jan 21, 2025 | SELL | 27,199 | $1.78 | $48.4K | Form 4 |
| MESSEMER DEBORAH M. | director | Dec 9, 2024 | SELL | 9,136 | $2.18 | $19.9K | Form 4 |
| Humer Franz B | director | Dec 5, 2024 | SELL | 9,221 | $2.16 | $19.9K | Form 4 |
| Parker Geoffrey M. | CHIEF FINANCIAL OFFICER | Oct 21, 2024 | TAX W/H | 36,404 | $2.84 | $103.4K | Form 4 |
| Douglas Earl Martin | SVP, General Counsel | Aug 21, 2024 | TAX W/H | 28,310 | $2.79 | $78.8K | Form 4 |
| MESSEMER DEBORAH M. | director | Jun 18, 2024 | SELL | 18,641 | $2.28 | $42.5K | Form 4 |
| Yoshiyama Annie | SVP, Finance | Jun 5, 2024 | DISPOSED | 0 | — | — | Form 4 |
| Yoshiyama Annie | SVP, Finance | Jun 5, 2024 | DISPOSED | 348,708 | $3.98 | $1.4M | Form 4 |
| Mayo Stephen | director | Jun 5, 2024 | AWARD | 191,082 | $2.44 | $466.2K | Form 4 |
| Barrett Elizabeth A. | director | Jun 5, 2024 | AWARD | 191,082 | $2.44 | $466.2K | Form 4 |
| SATO VICKI L | director | Jun 5, 2024 | AWARD | 61,475 | — | — | Form 4 |
| SATO VICKI L | director | Jun 5, 2024 | AWARD | 95,541 | $2.44 | $233.1K | Form 4 |
| Humer Franz B | director | Jun 5, 2024 | AWARD | 61,475 | — | — | Form 4 |
| Humer Franz B | director | Jun 5, 2024 | AWARD | 95,541 | $2.44 | $233.1K | Form 4 |
| WITTE OWEN N. | director | Jun 5, 2024 | AWARD | 191,082 | $2.44 | $466.2K | Form 4 |
| Kazam Joshua A | director | Jun 5, 2024 | AWARD | 191,082 | $2.44 | $466.2K | Form 4 |
| MESSEMER DEBORAH M. | director | Jun 5, 2024 | AWARD | 122,950 | — | — | Form 4 |
| Humer Franz B | director | May 30, 2024 | SELL | 11,200 | $2.34 | $26.2K | Form 4 |
| Belldegrun Arie | director | May 16, 2024 | BUY | 1,724,137 | $2.90 | $5.0M | Form 4 |
| Belldegrun Arie | director | May 16, 2024 | AWARD | 344,828 | $2.90 | $1.0M | Form 4 |
| Parker Geoffrey M. | CHIEF FINANCIAL OFFICER | May 16, 2024 | AWARD | 344,828 | $2.90 | $1.0M | Form 4 |